Protein Sciences Corporation, a leading entity in the biotechnology industry, is headquartered in the United States. Founded in 1983, the company has made significant strides in the development of innovative protein-based solutions, particularly in the fields of vaccine production and biopharmaceuticals. With a focus on advanced protein expression systems, Protein Sciences is renowned for its proprietary technologies, which enhance the efficiency and safety of vaccine manufacturing. Their flagship product, the Flublok® vaccine, stands out for its unique recombinant technology, offering a more effective alternative to traditional flu vaccines. Recognised for its commitment to quality and innovation, Protein Sciences has established a strong market position, contributing to public health initiatives and advancing the biotechnology landscape. The company continues to play a pivotal role in addressing global health challenges through its cutting-edge research and development efforts.
We don't have data for Protein Sciences Corporation, but we can show you information about their parent organization instead.
View parent company